Second, in SLE patients, higher levels of PP2A drive the dephosphorylation of the transcription factor Elf-1, inhibiting the binding of Elf-1 to the CD3ζ and FcRγ promoters. The gene discussed is CD247; the disease is systemic lupus erythematosus.